HF  Surveyor Capital

https://www.citadel.com/investment-strategies /surveyor-capital/

     Office Locations:

300 Crescent Court, Suite 250
Dallas, TX 75201
Phone: 972-892-1700

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.


  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Established in 2008, Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel Investment's three fundamental equities businesses. Surveyor's independent sector-aligned portfolio teams take a diligent, bottom-up investment approach. Citadel invests in companies in the Communications, Consumer, Energy, Financials, Healthcare, Industrials, Media and Entertainment, and Technology sectors. The team is made up of over 175 investment professionals.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    James Yeh President and Co-Chief Investment Officer
    Todd Barker Head of Surveyor Capital


    Recent Funding Events (trailing 12 months):







      TRIANA Biomedicines



      Seed and Series A





      Series C


      Arkuda Therapeutics



      Series B


    Portfolio companies include:


    Recent News: